{"id":27477,"date":"2014-08-05T09:25:47","date_gmt":"2014-08-05T13:25:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=27477"},"modified":"2014-08-05T09:25:47","modified_gmt":"2014-08-05T13:25:47","slug":"galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477","title":{"rendered":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/05\/2014 (wallstreetpr) \u2013 The largest developer of therapeutics targeting galectin proteins to cure cancer and fibrosis, <b>Galectin Therapeutics Inc., (NASDAQ:GALT)<\/b> issued a <a href=\"http:\/\/www.marketwatch.com\/story\/galectin-therapeutics-responds-to-class-action-lawsuit-2014-08-04\">crucial declaration<\/a> on August 4, 2014.<\/p>\n<p style=\"text-align: justify;\"><b>The putative class action<\/b><\/p>\n<p style=\"text-align: justify;\">Galectin Therapeutics Inc. (NASDAQ:GALT)\u00a0has learnt that an alleged class action lawsuit has been lodged against Galectin Therapeutics along with some officers of the company claiming violations of United States federal securities laws. The company disputes the allegations and also proposes to protect vigorously against the court case.<\/p>\n<p style=\"text-align: justify;\"><b>CMO of the company commented <\/b><\/p>\n<p style=\"text-align: justify;\">The President and Chief Medical Officer of Galectin Therapeutics, Peter G. Traber, M.D., commented that the company is in the business of drug development and has faith and confidence in it. Also, the company&#8217;s clinical and preclinical experiments continue to remain as Galectin&#8217;s central concerns. Traber added that the company is certainly saddened to know about the lawsuit, which was recently lodged. However, Galectin thinks that allegations are without merit.<\/p>\n<p style=\"text-align: justify;\">Traber continued that the company plans to guard itself vigorously in this issue, and its board of directors as well as management team will continue to stay focussed on its drug development business. In addition,\u00a0Galectin Therapeutics Inc. (NASDAQ:GALT) will continue to proceed forward with enrolment of its third group of patients in its Phase 1 clinical test analysing its galectin inhibitor GR-MD-02 in fatty liver disease with advanced-level fibrosis.<\/p>\n<p style=\"text-align: justify;\"><b>The investigation<\/b><\/p>\n<p style=\"text-align: justify;\">The Law offices of Howard G. Smith declared that it was probing the possible allegations on behalf of the investors of the company. The investigation, besides concerning probable breach of federal securities law, also emphasizes on explicit statements issued by the company regarding its business as well as financial prospects.<\/p>\n<p style=\"text-align: justify;\">Almost a week back,\u00a0Galectin Therapeutics Inc. (NASDAQ:GALT) unveiled the fruits of cohort two of its phase 1 clinical experiment. The test was carried out in patients suffering from NASH along with complex fibrosis. The results came out to be positive; however, the market responded pessimistically to its report.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/05\/2014 (wallstreetpr) \u2013 The largest developer of therapeutics targeting galectin proteins to cure cancer and fibrosis, Galectin Therapeutics Inc., (NASDAQ:GALT) issued a crucial [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":27479,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[5130,5131],"stock_ticker":[],"class_list":["post-27477","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-galectin-therapeutics-inc-nasdaqgalt","tag-nasdaqgalt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/05\/2014 (wallstreetpr) \u2013 The largest developer of therapeutics targeting galectin proteins to cure cancer and fibrosis, Galectin Therapeutics Inc., (NASDAQ:GALT) issued a crucial [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-05T13:25:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"168\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations\",\"datePublished\":\"2014-08-05T13:25:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\"},\"wordCount\":339,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg\",\"keywords\":[\"Galectin Therapeutics Inc. (NASDAQ:GALT)\",\"NASDAQ:GALT\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\",\"name\":\"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg\",\"datePublished\":\"2014-08-05T13:25:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg\",\"width\":300,\"height\":168},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477","og_locale":"en_US","og_type":"article","og_title":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR","og_description":"Boston, MA 08\/05\/2014 (wallstreetpr) \u2013 The largest developer of therapeutics targeting galectin proteins to cure cancer and fibrosis, Galectin Therapeutics Inc., (NASDAQ:GALT) issued a crucial [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-05T13:25:47+00:00","og_image":[{"width":300,"height":168,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations","datePublished":"2014-08-05T13:25:47+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477"},"wordCount":339,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg","keywords":["Galectin Therapeutics Inc. (NASDAQ:GALT)","NASDAQ:GALT"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477","url":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477","name":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg","datePublished":"2014-08-05T13:25:47+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/index1.jpg","width":300,"height":168},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/galectin-therapeutics-inc-nasdaqgalt-to-shield-itself-forcefully-against-the-allegations-27477#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Galectin Therapeutics Inc. (NASDAQ:GALT) To Shield Itself forcefully Against The Allegations"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=27477"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/27477\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/27479"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=27477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=27477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=27477"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=27477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}